 | Up a level |
Faetkenheuer, G., Jessen, H., Stoehr, A., Jung, N., Jessen, A. B., Kuemmerle, T., Berger, M., Bogner, J. R., Spinner, C. D., Stephan, C., Degen, O., Vogelmann, R., Spornraft-Ragaller, P., Schnaitmann, E., Jensen, B., Ulmer, A., Kittner, J. M., Haerter, G., Malfertheiner, P., Rockstroh, J., Knecht, G., Scholten, S., Harrer, T., Kern, W. V., Salzberger, B., Schuermann, D. and Ranneberg, B. (2016). PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis. HIV Med., 17 (6). S. 453 - 460. HOBOKEN: WILEY. ISSN 1468-1293
Knops, E., Kalaghatgi, P., Neumann-Fraune, M., Heger, E., Schuelter, E., Lengauer, T., Keitel, V., Goeser, T., Schuebel, N., von Hahn, T., Peuser, I., Qurishi, N., Roemer, K., Scholten, S., Daeumer, M., zur Wiesch, J. S., Baumgarten, A., Obermeier, M., Walter, H., Kaiser, R. and Sierra, S. (2016). HEPATITIS C VIRUS SCREENING PROJECT OF PATIENTS ON CURRENT ANTI-HCV THERAPY. J. Hepatol., 64. S. S402 - 1. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1600-0641
Sikorski, A. M., Sierra, S., Rupp, D., Beggel, B., Lengauer, T., Goeser, T., Qurishi, N., Scholten, S., Bartenschlager, R. and Kaiser, R. (2014). Phenotypic analysis of patients on current anti-HCV therapy. Antivir. Ther., 19. S. A110 - 1. LONDON: INT MEDICAL PRESS LTD. ISSN 1359-6535